EP1239923A2 - Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux - Google Patents

Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux

Info

Publication number
EP1239923A2
EP1239923A2 EP00983353A EP00983353A EP1239923A2 EP 1239923 A2 EP1239923 A2 EP 1239923A2 EP 00983353 A EP00983353 A EP 00983353A EP 00983353 A EP00983353 A EP 00983353A EP 1239923 A2 EP1239923 A2 EP 1239923A2
Authority
EP
European Patent Office
Prior art keywords
composition according
volume
weight
ribavirin
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00983353A
Other languages
German (de)
English (en)
Inventor
Abdul Rahman Shoa'a
El-Banna Hossny
Da'as Kefah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEW PHARMA RESEARCH SWEDEN AB
Original Assignee
New Pharma Research Sweden AB
Newpharmaresearch Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Pharma Research Sweden AB, Newpharmaresearch Sweden AB filed Critical New Pharma Research Sweden AB
Priority to EP00983353A priority Critical patent/EP1239923A2/fr
Publication of EP1239923A2 publication Critical patent/EP1239923A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions destinées au traitement prophylactique et/ou thérapeutique de maladies virales, de préférence chez les volailles, comprenant comme ingrédients actifs essentiels la ribavirine et au moins un autre agent antiviral ou ses dérivés chimiques actifs et un agent stabilisant. Eventuellement, les compositions comprennent également un ou plusieurs antibiotiques du type quinolone, des vitamines et/ou des conservateurs. Les compositions sont stables lors du stockage sous la forme sous laquelle elles sont destinées à être administrées aux volailles, c'est-à-dire par injection, par voie orale ou par pulvérisation. Une thérapie combinée avec un vaccin ou une combinaison avec des antibiotiques est également possible. L'invention concerne également l'utilisation combinée de la ribavirine et d'autres agents antiviraux dans le traitement de maladies virales animales.
EP00983353A 1999-12-20 2000-12-20 Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux Withdrawn EP1239923A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP00983353A EP1239923A2 (fr) 1999-12-20 2000-12-20 Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99125414 1999-12-20
EP99125414 1999-12-20
EP00983353A EP1239923A2 (fr) 1999-12-20 2000-12-20 Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux
PCT/EP2000/013017 WO2001045727A2 (fr) 1999-12-20 2000-12-20 Compositions veterinaires

Publications (1)

Publication Number Publication Date
EP1239923A2 true EP1239923A2 (fr) 2002-09-18

Family

ID=8239666

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00983353A Withdrawn EP1239923A2 (fr) 1999-12-20 2000-12-20 Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux

Country Status (3)

Country Link
EP (1) EP1239923A2 (fr)
AU (1) AU2012101A (fr)
WO (1) WO2001045727A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1782826A1 (fr) * 2005-11-08 2007-05-09 GBF Gesellschaft für Biotechnologische Forschung mbH PQS, c-diGMP et leurs conjugués utilisés comme adjuvants et leur emploi dans des compositions pharmaceutiques
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
CN105021756B (zh) * 2015-07-01 2017-03-01 山东世通检测评价技术服务有限公司 一种禽蛋中金刚烷胺、金刚乙胺、利巴韦林、吗啉胍残留的多联检测方法
EP3600555A4 (fr) * 2017-05-01 2020-10-28 Iraj E. Kiani Compositions antivirales et procédé associé
CN109431981B (zh) * 2018-11-26 2020-02-14 天津市中升挑战生物科技有限公司 一种恩诺沙星注射液及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017282A1 (fr) * 1996-10-23 1998-04-30 Vertex Pharmaceuticals Incorporated Procedes d'utilisation d'un octosulfate de saccharose pour le traitement ou la prevention d'une infection a virus enveloppe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
AU5885690A (en) * 1989-07-11 1991-01-17 Union Carbide Chemicals And Plastics Company Inc. Emulsions comprising aminopolysaccharides
IL105090A (en) * 1992-03-18 1998-08-16 Us Bioscience Acid N) phosphonoacetyl (Aspartic L in a broad spectrum antiviral agent
WO1997013528A1 (fr) * 1995-10-12 1997-04-17 Gs Development Ab Composition pharmaceutique pour l'administration d'un principe actif sur ou au travers d'une surface cutanee ou muqueuse
CA2206047A1 (fr) * 1997-05-23 1998-11-23 Romeo Rang (Deceased) Compositions immunomodulantes pour le traitement de troubles attribuables aux virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017282A1 (fr) * 1996-10-23 1998-04-30 Vertex Pharmaceuticals Incorporated Procedes d'utilisation d'un octosulfate de saccharose pour le traitement ou la prevention d'une infection a virus enveloppe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0145727A3 *

Also Published As

Publication number Publication date
WO2001045727A2 (fr) 2001-06-28
AU2012101A (en) 2001-07-03
WO2001045727A3 (fr) 2002-06-06

Similar Documents

Publication Publication Date Title
KR102265798B1 (ko) 코로나 바이러스에 연관된 감염의 치료를 위한 항바이러스 조성물
KR101440629B1 (ko) 바이러스 감염을 시스테아민 화합물로 치료하는 물질들 및방법들
IL140720A (en) Use of Prenzyl protein inhibitors for the preparation of a pharmaceutical preparation for the treatment of arthritis
CN1121232C (zh) 治疗疱疹的药物组合物
US20090304630A1 (en) Treating severe and acute viral infections
EA037085B1 (ru) Композиция для устранения заложенности носа, обладающая противовирусным действием
Smee et al. Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent
KR101342065B1 (ko) 아시클로비어 제제
Alenius et al. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs
US20220288050A1 (en) Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics
EP4094763A1 (fr) Utilisation d'un composé dans la prévention et/ou le traitement de l'infection par un pathogène chez les animaux
EP1239923A2 (fr) Compositions veterinaires stabilisees, contenant plusieurs agents antiviraux
JPH0285215A (ja) Ｂ型肝炎の抗ウイルス剤による治療方法
Elia et al. In vitro inhibition of caprine herpesvirus 1 by acyclovir and mizoribine
US4880785A (en) Topical process for treating herpes infections using 5-isopropyl-2'-β-d
US20230414695A1 (en) Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis
Burkhardt et al. Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig
NL2033127A (en) Compositions and methods for enhancing and expanding infection induced immunity
RU2375057C2 (ru) Антигельминтный препарат для лечения мелкого рогатого скота
US8524690B2 (en) DNA polymerase inhibitors composition and methods
KR100930480B1 (ko) 신규 디아릴 헵타노이드계 화합물 및 그 용도
KR101876019B1 (ko) 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법
RU2559179C1 (ru) Фармацевтическая композиция для лечения тяжелых форм вирусных инфекций в виде таблеток
Johnson et al. Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds
Hartmann Feline upper respiratory tract infection-management of problem cases.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020625

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEW PHARMA RESEARCH SWEDEN AB

17Q First examination report despatched

Effective date: 20050214

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060824